Faculty

More documents

Recommendations

Info

Bernard HAMELIN, MD ISMO EU Medical Director Bernard is European Medical Director of AstraZeneca, Regional office in Brussels, Belgium. Bernard obtained his Medical degree at the University of Paris, School of Medicine in 1983 and received his Master in Science degree in Pharmacology and Cellular Biology at the University of Paris in 1987. Later in 1993, he obtained his eMBAfrom the "Institut Administration des Entreprises" at the University of Paris. Bernard practiced at the Hospital of Marseille in Oncology and Radiotherapy and in the Hospital of Paris in the departments of Hepatogastroenterology, ICU, Kidney Transplantation, Virology and Haematology. His residency and fellowship was performed in the department of hepatogastro-enterology. He joined Astra France in 1991 as Clinical Research Physician, Medical Responsible for GI and moved to Astra Hässle in Mölndal, Sweden in 1994 as Project Team Leader of the mosapride project team. In 1997, Bernard moved to Astra Merck Pharmaceuticals, PA, USAas Clinical Research Physician and was the Medical responsible for Nexium (phase II/III) and supported the pre-launch marketing activities for phase IIIb/IV. In 1999 he was promoted Global Director GI Therapeutical Area and he returned to AstraZeneca France in 2001 where he was appointed Medical Director. In 2005, Bernard joined AstraZeneca ISMO, as EU Medical Director and is responsible for the Medical Affairs, Clinical Research and Medical Information. ____________________________________________________________________________ Desmond JULIAN Professor Desmond Julian undertook his undergraduate medical education in Cambridge and London, and trained in cardiology at the National Heart Hospital, London, Harvard Medical School, and Edinburgh. In 1961 he was the first to put forward the concept of the coronary care unit in an article in the Lancet. In 1962, he went to Sydney, Australia to set up one of the first coronary units. He was Cardiologist in the Royal Infirmary Edinburgh from 1964 to 1975 and Professor of Cardiology in the University of Newcastle-upon-Tyne from 1975 to 1986, and subsequently Medical Director of the British Heart Foundation from 1986 to 1993. He was President of the British Cardiac Society from 1985-87. He was awarded the Gold Medal of the European Society of Cardiology in 1998. He received the Mackenzle Medal of the British Cardiac Society in 2003 and the International Service Award of the American College of Cardiology in 2005. He was awarded Honorary MDs from the Universities of Gothenburg and Edinburgh. He was Editor of the European Heart Journal from its inception in 1979 to 1988. He is the author or editor of some 20 books on cardiological topics. He has been involved in the design, monitoring and analysis of many of the major clinical trials in cardiology , including ISIS trials, CONSENSUS and 4S.
Abraham M. KARKOWSKY, M.D., Ph.D. Education - B.S. Brooklyn College, Brooklyn, N.Y. (1969) - S.M. Massachusetts Institute of Technology, Organic Chemistry (1972) - Ph.D. Mount Sinai School of Medicine, Biomedical Sciences-Pharmacology (1977) - M.D. University of Miami School of Medicine (Ph.D. to M.D. program) (1980) Additional Training - Post-doctoral fellowship in Medicinal Chemistry, Sidney Farber Cancer Center. 1977-1978 - Post-doctoral Fellowship in Genetics, NIH 1983-86 Medical Training - Internship-residency in pediatrics Albert Einstein College of Medicine, Bronx Municipal Hospital Center, 1980-83 Work history FDA- 1986-current - Medical reviewer 1986-89 - Team Leader 1989-Current - Acting deputy director- 2006-7 (intermittent). Practice Moonlighter: - Prince George hospital 1984-91 - Southern Maryland Hospital 1985-87 - Office practice 1994-99 (part time) ____________________________________________________________________________ Hélène KOLSKY Since January 2007 dismissed after an acquisition by MEDA From 2000 to January 2007: 3M healthcare From February 2004 to January 2007: scientific & institutional affairs Manager From 2002 to 2004 : European position as medical manager MENA& North Africa January 2000-february 2004 : Medical manager, Therapeutic areas: Cardiology, Dermatology / Immunology, Respiratory. 1992 - 1999: BAYER PHARMA: Manager of the all therapeutic areas (cardiology, metabolism, CNS) 1979 - 1992: HOECHST: clinical project leader and then manger of the cardiovascular area (5 physicians)
Page 1 and 2: Faculty
Page 3 and 4: GUSTAFSSON Finn Department of Cardi
Page 5 and 6: STAGNITTO Maria Director Office of
Page 7 and 8: Jeffrey S. BORER,M.D Biographical S
Page 9 and 10: Gad COTTER, MD, FACC EDUCATION/TRAI
Page 11 and 12: Nancy L. GELLER She has been the Di
Page 13: Finn GUSTAFSSON, M.D., Ph.D. Educat
Page 17 and 18: Philippe LECHAT Professor Philippe
Page 19 and 20: Bertram PITT M.D. Education 1945-49
Page 21 and 22: James H. REVKIN, MD, FACC, FACP Sen
Page 23 and 24: Charles L. SHEAR, Dr.P.H., F.A.H.A.
Page 25 and 26: Philippe Gabriel STEG, MD, FESC, FA
Page 27 and 28: Hans WEDEL I have been professor in

Faculty

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?